Search - tctmd.com

Displaying 81 - 100 of 420

Sort: Relevancy | Date

Presentation NY Valves 2024

DurAVR: Impact of Biomimetic Design on Restoration of Hemodynamics in Early ViV Experience

Presenter: Anita W. Asgar

June 06, 2024

Presentation NY Valves 2024

Case Presentation III: High Risk Mitral VIV for LVOTO

Presenter: Shmuel Chen

June 06, 2024

Presentation NY Valves 2024

TAVR in Bicuspid Mega-Annulus and Critical AS

Presenter: Vivek Patel

June 05, 2024

Presentation Fellows 2024

LAA Closure, PFO Closure, and Other Novel Structural Heart Procedures

Presenter: Vivian G. Ng

April 13, 2024

Presentation THT 2024

Ex Vivo Gene Therapy in Cardiac Allografts

Presenter: Dawn E. Bowles

March 06, 2024

Presentation THT 2024

Metabolic Modulation in Ex-Vivo Perfusion Models: Are We There Yet?

Presenter: Eduardo Rame

March 06, 2024

Presentation THT 2024

In-vivo Pressure-Volume Reconstructions to Evaluate Immediate Changes in Left Ventricular Cardiomechanics Following Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis

Presenter: Antoon van den Enden

March 05, 2024

Presentation THT 2024

Case 4: TMVR VIV With a Surprise

Presenter: Jeffrey Heslop

March 05, 2024

Presentation THT Abstracts 2024

Impact of obesity on different In-hospital outcomes after placement of left atrial appendage occlusion device (LAAOD)

Presenter: Vivek Jha

March 04, 2024

Presentation THT Abstracts 2024

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation Miami Valves 2024

Structural Heart Disease and Treatment

Presenter: Vivian Avila

February 03, 2024

Presentation Miami Valves 2024

A Novel Technique of Prosthetic Leaflet Modification to Enable ViV TMVR

Presenter: Nikolaos Spilias

February 01, 2024

Presentation TCT 2023

Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

Presenter: Josep Rodés-Cabau

October 26, 2023

Presentation TCT 2023

LAAO as First Line Stroke Prevention Therapy: Are CHAMPION-AF and CATALYST Trials Likely to Succeed?

Presenter: Vivek Reddy

October 26, 2023

Presentation TCT 2023

This Is the Way I Do Amulet: Please Disagree With Every Single Step!

Presenter: Vivek Reddy

October 25, 2023

Presentation TCT 2023

TCT 220: Stent Elongation in-Vivo is Mediated by Lesion Morphology as Defined by OCT.

Presenter: Michael McGarvey

October 25, 2023

Presentation TCT 2023

Prevention and Management of Coronary Obstruction in VIV-TAVR

Presenter: Susheel Kodali

October 25, 2023

Presentation TCT 2023

TCT 25: In vivo validation of intra-coronary absolute flow measurements and hyperemia using continuous coronary thermodilution

Presenter: Lennert Minten

October 25, 2023

Presentation TCT 2023

TCT 350: Statistics of In-patient Mortality and Associated Variables of Transcatheter Mitral Valve-in-Valve (TMVR ViV) Procedure in Mitral Stenosis and Mitral Regurgitation with Bioprosthetic Valve- A Nationwide Analysis

Presenter: Aneeza Jamshed

October 25, 2023

Advertisement

DurAVR: Impact of Biomimetic Design on Restoration of Hemodynamics in Early ViV Experience

Case Presentation III: High Risk Mitral VIV for LVOTO

TAVR in Bicuspid Mega-Annulus and Critical AS

LAA Closure, PFO Closure, and Other Novel Structural Heart Procedures

Ex Vivo Gene Therapy in Cardiac Allografts

Metabolic Modulation in Ex-Vivo Perfusion Models: Are We There Yet?

In-vivo Pressure-Volume Reconstructions to Evaluate Immediate Changes in Left Ventricular Cardiomechanics Following Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis

Case 4: TMVR VIV With a Surprise

Impact of obesity on different In-hospital outcomes after placement of left atrial appendage occlusion device (LAAOD)

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Structural Heart Disease and Treatment

A Novel Technique of Prosthetic Leaflet Modification to Enable ViV TMVR

Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

LAAO as First Line Stroke Prevention Therapy: Are CHAMPION-AF and CATALYST Trials Likely to Succeed?

This Is the Way I Do Amulet: Please Disagree With Every Single Step!

TCT 220: Stent Elongation in-Vivo is Mediated by Lesion Morphology as Defined by OCT.

Prevention and Management of Coronary Obstruction in VIV-TAVR

TCT 25: In vivo validation of intra-coronary absolute flow measurements and hyperemia using continuous coronary thermodilution

TCT 350: Statistics of In-patient Mortality and Associated Variables of Transcatheter Mitral Valve-in-Valve (TMVR ViV) Procedure in Mitral Stenosis and Mitral Regurgitation with Bioprosthetic Valve- A Nationwide Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content